eFront Pevara private equity benchmarks updated with Q2 2019 results
Paris, September 18, 2019 – eFront Pevara, private equity benchmarks have now been updated, incorporating results up to June 30, 2019. …
Axil Capital will benefit from eFront Invest GP’s suite of automated fund management tools encompassing intuitive accounting, advanced reporting and streamlined workflows within a centralized industry-leading solution. eFront Invest GP has now been adopted by more than 500 general partners and asset servicers worldwide.
Fred Shane, Managing Partner at Axil Capital said, “We chose eFront because it offers the most comprehensive solution for venture capital and private equity firms, encompassing all aspects of the investment life cycle. Adoption of eFront Invest GP will allow us to process large volumes of data, quickly and accurately, without increasing our internal resources. We were particularly attracted to eFront’s combination of ready-made template solutions that can be further customized to address our specific needs.”
John Legrand, Managing Director Asia-Pacific at eFront added, “Axil Capital’s adoption of eFront Invest GP is a further endorsement of eFront’s leading position in Asia-Pacific markets, including Japan. We look forward to working with Axil and supporting their core business.”
Axil Capital was spun out of Mizuho Securities in 2017, with early investors that include Mizuho, the Japanese government, a global pharma, and a small group of visionary investors from inside and outside of Japan. Its goal is to create synergies between the biotech ecosystem in Japan and the rest of the world, resulting in great companies and great returns for their investors. With one fund and 40M in assets under management, Axil focuses on innovation in biotechnology.